11min chapter

Biotech Hangout cover image

Episode 132 - February 21, 2025

Biotech Hangout

CHAPTER

Bluebird's Battle: A Biotech Struggle

This chapter examines the recent acquisition of Bluebird by private equity firms as it grapples with financial woes and competition from Chinese biotech firms. The discussion delves into the challenges of turning innovative gene therapy advances into successful commercial products and the potential impact on patient care. Amidst skepticism regarding profitability and management decisions, there remains cautious optimism for Bluebird's future under new ownership.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode